Evolution of bone density after heart transplantation: Influence of anti-resorptive therapy.

被引：0
|
作者：
Gil-Fraguas, L [1 ]
Jodar, E [1 ]
Martinez, G [1 ]
Escalona, MA [1 ]
Vara, J [1 ]
Robles, E [1 ]
Hawkins, F [1 ]
机构：
[1] Univ Hosp 12 Octubre, Madrid, Spain
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [21] OSTEOPOROSIS PATIENTS WITH HIGH BONE TURNOVER MARKER ARE MORE LIKELY TO DEVELOP HYPOCALCEMIA AFTER RECEIVING ANTI-RESORPTIVE THERAPY
    Nakano, Chikako
    Hamano, Takayuki
    Matsui, Isao
    Rakugi, Hiromi
    Isaka, Yoshitaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [22] ANTI-RESORPTIVE THERAPY COMPROMISES BONE'S MATERIAL COMPOSITION PREDISPOSING TO ATYPICAL FEMORAL FRACTURES
    Zebaze, R.
    Chiang, C. Y.
    Nguyen, H.
    Peng, Y.
    Ghasem-Zadeh, A.
    Wang, X. -F.
    Iuliano, S.
    Zanchetta, M. B.
    Zanchetta, J. R.
    Ebeling, P. R.
    Seeman, E.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S375 - S376
  • [23] SEQUENTIAL ANABOLIC AND ANTI-RESORPTIVE THERAPY IN PATIENTS WITH SEVERE OSTEOPOROSIS
    Gutierrez, La'ali Q. Imam
    Kelly, Clive
    Mekkayil, Babitha
    Tuck, Stephen
    RHEUMATOLOGY, 2017, 56 : 83 - 83
  • [24] Effect of calcitonin, a bone anti-resorptive agent, on bone metabolism in cholestatic patients following orthotopic liver transplantation (OLT)
    Guichelaar, MMJ
    Clarke, BL
    Malinchoc, M
    Hay, JE
    JOURNAL OF HEPATOLOGY, 2003, 38 : 194 - 194
  • [25] Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects
    Garcia-Gomez, Antonio
    Ocio, Enrique M.
    Crusoe, Edvan
    Santamaria, Carlos
    Hernandez-Campo, Pilar
    Blanco, Juan F.
    Sanchez-Guijo, Fermin M.
    Hernandez-Iglesias, Teresa
    Brinon, Jesus G.
    Fisac-Herrero, Rosa M.
    Lee, Francis Y.
    Pandiella, Atanasio
    San Miguel, Jesus F.
    Garayoa, Mercedes
    PLOS ONE, 2012, 7 (04):
  • [26] Anti-resorptive Drugs and their Impact on Maxillofacial Bone among Cancer Patients
    Borumandi, Farzad
    Aghaloo, Tara
    Cascarini, Luke
    Gaggl, Alexander
    Fasanmade, Kunmi
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (06) : 736 - 743
  • [27] Effect of anti-resorptive agents on fracture rates in subjects selected for therapy on the basis of clinical risk factors or low bone mineral density
    Kung, A. W. C.
    Lee, K. K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S333 - S333
  • [28] Increases in bone mineral density explain the reduction in incidence of nonvertebral fractures seen with anti-resorptive therapy in women with postmenopausal osteoporosis.
    Hochberg, MC
    Greenspan, S
    Miller, PD
    Wasnich, RD
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S383 - S383
  • [29] Treatment of fracture non-union in a young adult with combination anabolic and anti-resorptive bone therapy
    Corrigan, Ruth A.
    Miller, Anne
    McNally, Martin A.
    Javaid, M. Kassim
    RHEUMATOLOGY, 2013, 52 (06) : 1147 - 1149
  • [30] Assessing bone health in osteoporotic postmenopausal women on anti-resorptive therapy using sensitive biochemical markers
    Puri, V
    Jacob, S
    Shah, R
    Saardekar, L
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (06) : 963 - 963
12345